Evolve Your Success

MAY 8, 2024

Picture a tool that does more than just scratch the surface; we’re talking about a deep dive into healthcare practitioner’s activities, from the operating room to prescription trends. Over the past decade, he has been a regular angel investor and company builder, typically focusing on data-driven topics.

Medical sales 52

Medical sales Sales Strategy Medical Sales 52

Pharmaceutical Technology

DECEMBER 5, 2022

According to the deal, Incyte is entitled to receive an upfront payment from CMS, which will also make further potential payments on meeting development, regulatory and commercial milestones. Ruxolitinib cream is the first topical inhibitor of JAK to obtain approval in the US.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Food Patients 52

Copyright Clearance Center

OCTOBER 3, 2023

Copyrighted material is fuel for AI systems,” said Tracey Armstrong, President and CEO, CCC. trillion of value to the global economy annually, according to a report from McKinsey Global Institute published in June. October 3, 2023 – Danvers, Mass. – Generative AI is set to add up to $4.4

Training 118

Training Media Leads Marketing 118

Pharmaceutical Technology

JUNE 19, 2023

Laurus Labs CEO Satyanarayana Chava stated: “This collaboration exhibits our commitment towards the cell and gene therapy (CGT) space. Topic sponsors are not involved in the creation of editorial content. Laurus Labs will be responsible for launching these products in India and emerging markets.

Pharmaceutical 98

Pharmaceutical Marketing Pharma Leads 98

Pharmaceutical Technology

FEBRUARY 23, 2023

GenScript ProBio CEO Dr Brian Min said: “We are delighted to enter into this strategic partnership with RVAC Medicines. The company provides end-to-end contract development and manufacturing organisation (CDMO) services from the discovery to the commercialisation of drugs.

Manufacturing 115

Manufacturing Medicine Consulting Pharmaceutical 115

pharmaphorum

NOVEMBER 11, 2022

Our CEO & Founder, Roberto Ascione , has been invited to close Day 2 of the virtual AHIMA22 Global Conference as a keynote speaker, November 11, 2022. The conference connects passionate health information professionals with the industry’s leading voices to cover the latest hot topics in healthcare.

Networking 52

Networking Healthcare Healthcare Leads 52

Pharmaceutical Technology

APRIL 12, 2023

LyGenesis CEO and co-founder Dr Michael Hufford said: “We’re thrilled to announce our collaboration with Imagine Pharma to utilise their unique cell-source with our use of endoscopic ultrasound engraftment of cell therapies into the lymph node for the treatment of diabetes. According to the company, around 1.45

Pharma 98

Pharma Leads Patients Pharmaceutical 98

Pharmaceutical Technology

APRIL 19, 2023

Arcutis Biotherapeutics president and CEO Frank Watanabe stated: “The acceptance of the NDA for roflumilast foam marks a major milestone toward our goal of bringing a steroid-free, topical foam treatment option to market, addressing a significant unmet need for individuals living with seborrheic dermatitis.

Food and Drug Administration 52

Food and Drug Administration FDA Safety Prescription 52

Pharmaceutical Technology

AUGUST 25, 2022

The approval is based on comprehensive data from the clinical development programme of Roctavian, including two-year findings from the international Phase III GENEr8-1 clinical trial. Topic sponsors are not involved in the creation of editorial content.

Medicine 105

Medicine Pharmaceutical Marketing Healthcare 105

Pharmaceutical Technology

JUNE 13, 2023

The funding, with participation from Oxford Science Enterprises (OSE), includes AGTC’s acquisition and capital to help accelerate Beacon Therapeutics’ candidate development. Beacon Therapeutics says it expects 12-month data from the SKYLINE trial in H2 2023. Topic sponsors are not involved in the creation of editorial content.

Leads 98

Leads Pharmaceutical Patients 98

Pharmaceutical Technology

MAY 30, 2023

Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases] for its gene therapy AMP-201. Topic sponsors are not involved in the creation of editorial content.

Safety 97

Safety Patients Leads Pharmaceutical 97

Pharmaceutical Technology

AUGUST 2, 2022

Subsequently, technology transfer as well as scale-up from the lab bench to the commercial facility of Samsung were carried out in a period of seven months. GreenLight’s process from formulation of the drug substance and lipid nanoparticle to bulk drug product can be carried out in this facility.

Engineering 104

Engineering Manufacturing Pharmaceutical 104

Pharmaceutical Technology

APRIL 14, 2023

Twist Bioscience CEO and co-founder Emily Leproust said: “With the dramatic increase in interest around cell and gene therapies, the addition of Twist CAR and TCR Libraries offers an important and differentiated tool to enable the development of the next generation of treatments for those suffering from a wide range of diseases.

Leads 98

Leads Pharmaceutical Patients 98

Pharmaceutical Technology

AUGUST 4, 2022

of total machine learning jobs - up from 62.6% The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time.

Pharmaceutical 105

Pharmaceutical Leads Marketing 105

Pharmaceutical Technology

MAY 19, 2023

Led by Hatteras Investment Partners, the financing round has seen participation from existing investors, including 8VC, Alexandria Venture Investments and Newpath Partners, along with new investors Moore Strategic Ventures and ARCH Venture Partners. Topic sponsors are not involved in the creation of editorial content.

Leads 98

Leads Patients Pharmaceutical 98

PM360

MARCH 22, 2024

We’re featuring AI in this month’s issue as the topic can’t be ignored—generative AI is creating huge waves in the Pharma industry and it’s all we’re talking about. There are ethical considerations around AI in Pharma, from protecting intellectual property, to providing accurate information, to programming bias, to name a few.

Ethics 52

Ethics Pharma Specialization Healthcare 52

PM360

MARCH 24, 2023

Many of the sessions focused on using psychedelics to help treat various conditions ranging from PTSD, anxiety, depression, and many others. With these games, anyone, anywhere can participate in virtual medical procedures ranging from cardio to derm and beyond. They were everywhere.

Media 119

Media Engineering Healthcare Healthcare 119

Pharmaceutical Technology

OCTOBER 11, 2022

LifeLink, LifeForce Capital, Selvridge, Backed VC, Khosla Ventures, Hermes-Epitek, AixThera, EIT, along with individual investors, Verge Genomics CEO Alice Zhang, BioAge CEO Kristen Fortney, and Recursion Pharmaceuticals chairman Marty Chavez have participated in the funding round.

Medicine 52

Medicine Pharmaceutical Patients 52

Pharmaceutical Technology

MAY 5, 2023

The EDS has been designed to deliver a topical anti-inflammatory high and deep into the sinuses and sino-nasal drainage tracts that are difficult to access. The EDS has been designed to deliver a topical anti-inflammatory high and deep into the sinuses and sino-nasal drainage tracts that are difficult to access.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Prescription 52

pharmaphorum

AUGUST 25, 2022

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. . Tune in to learn more. . You can listen to episode 58 of the? Podbean. .

52

52

Impetus Digital

JUNE 29, 2022

Register for Impetus’ upcoming live webinar on July 20, 10-11 AM ET: A Fireside Chat with Richard Houlihan, CEO of EirMed. Richard Houlihan , CEO of EirMed , will join Natalie Yeadon , Co-founder & CEO of Impetus Digital , for this live episode of Healthcare Goes Digital. About the webinar. Register for this free webinar.

Professional Services 52

Professional Services Healthcare Provider Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 31, 2023

Kenya’s investments, trade, and industry cabinet secretary Moses Kuria said: “This investment creates the momentum to meet the $10bn annual target under the government’s manufacturing ’20 by 30′ vision, where we plan to grow the contribution of manufacturing to GDP to 20% by the year 2030 from the current 7%.”

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

Pharmaceutical Technology

DECEMBER 23, 2022

As per the prior and expanded agreements, ProQR is entitled to get research, development and commercialisation milestone payments totalling up to nearly $3.75bn, apart from tiered royalty payments on sales of products. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

Pharmaceutical Technology

JULY 6, 2022

of total data analytics jobs - up from 11.1% The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. These key themes, which include data analytics, are chosen to cover "any issue that keeps a CEO awake at night". in the same quarter last year.

Pharmaceutical 98

Pharmaceutical Leads Marketing 98

Pharmaceutical Technology

DECEMBER 18, 2022

The application also comprised results data from a 25μg booster vaccine given to children of this age group following an initial vaccine regimen with Moderna’s Covid-19 vaccine. Additionally, the application included findings from a Phase II/III clinical trial of mRNA-1273.214. 5), mRNA-1273. 5), mRNA-1273.

Medicine 121

Medicine Marketing Pharmaceutical Leads 121

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna CEO Stéphane Bancel said: “Our new state-of-the-art facility will bring mRNA manufacturing to UK shores, providing the UK public with access to pandemic response capabilities through Moderna Covid-19 vaccines and future respiratory virus vaccine candidates. “We Topic sponsors are not involved in the creation of editorial content.

Government 140

Government Manufacturing Pharmaceutical Marketing 140

Impetus Digital

OCTOBER 5, 2022

Natalie Yeadon Co-Founder & CEO Natalie worked in the pharmaceutical industry for over 18 years in a variety of sales, marketing, and early brand commercialization management roles both in Canada and in the US, in several different therapeutic areas. He has also led three companies from start to successful exit. About the webinar.

Transportation 52

Transportation Professional Services Healthcare Healthcare 52

pharmaphorum

OCTOBER 18, 2022

Topical therapies like OCS-01 would complement current approaches by adding an option with improved patient comfort, safety, accessibility, cost, and allowing individualised dosing. The announced definitive business combination agreement is set to complete in H1 in 2023 in Lausanne, Switzerland and Amsterdam, Netherlands.

Biopharma 57

Biopharma Management Specialization Physicians 57

Pharmaceutical Technology

AUGUST 28, 2022

It has no plans to seek removal of Comirnaty from the market and will not seek an injunction to stop its sale in the future. The latest development comes after Moderna sought emergency use authorization from the US Food and Drug Administration for its BA.4/BA.5 Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 98

Food and Drug Administration Food Marketing Pharmaceutical 98

Pharmaceutical Technology

AUGUST 1, 2022

4/5 Omicron strain is being developed in line with the latest recommendations from the Food and Drug Administration (FDA). Moderna CEO Stéphane Bancel said: “Moderna’s mRNA platform is enabling us to rapidly create mRNA-1273.222, a bivalent vaccine that specifically targets Omicron subvariants BA.4 4/5 strain messenger RNA (mRNA).

Food and Drug Administration 115

Food and Drug Administration Government Food Pharmaceutical 115

Pharmaceutical Technology

FEBRUARY 8, 2023

The US Food and Drug Administration (FDA) has accepted Aldeyra Therapeutics’ new drug application (NDA) for topical ocular reproxalap to treat signs and symptoms of dry eye disease. Aldeyra’s application is supported by the data obtained from five adequate and well-controlled studies.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Food 52

Pharmaceutical Technology

MAY 16, 2023

ImmPACT Bio has received fast track designation (FTD) from the US Food and Drug Administration (FDA) for IMPT-314 to treat relapsed or refractory (R/R) aggressive B-cell lymphoma. It will also be used for the treatment of DLBCL arising from follicular lymphoma, following two or more lines of systemic therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Food Patients 52

Pharmaceutical Technology

MAY 3, 2023

BrightPath Biotherapeutics CEO Kenichi Nagai stated: “This collaboration with Artisan provides us with the potential to create highly engineered allogeneic iNKT cellular therapy programmes for a range of indications, including solid tumours. Topic sponsors are not involved in the creation of editorial content.

Engineering 52

Engineering Leads Safety Sales 52

Pharmaceutical Technology

APRIL 21, 2023

Moderna CEO Stéphane Bancel said: “Since our inception, we have always strived to be at the forefront of cutting-edge technology, leveraging innovations to deliver the greatest possible impact to people through mRNA medicines. Lipid nanoparticles protect mRNA molecules from degradation within the body.

Medicine 98

Medicine Networking Safety Leads 98

Pharmaceutical Technology

OCTOBER 13, 2022

Under the collaboration deal, Inceptor Bio will use the Solupore technology from Avectas instead of electroporation for engineering T cells to yield a healthier T cell. Topic sponsors are not involved in the creation of editorial content. This non-viral technology is well suited to the CAR-T cell process of Inceptor Bio.

Engineering 59

Engineering Pharmaceutical Manufacturing 59

Pharmaceutical Technology

JULY 12, 2022

The Roflumilast cream is a once-a-day topical formulation of the selective phosphodiesterase type 4 (PDE4) inhibitor, roflumilast. The NDS submission by Arcutis is based on positive findings from the company’s pivotal Phase III programme and two long-term open-label clinical trials. versus a vehicle rate of 6.1%

Food and Drug Administration 64

Food and Drug Administration Safety Food Pharmaceutical 64

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines CEO Dr Sean Fu said: “We are excited to begin this collaboration with Dr Weissman, a pioneer in the field of mRNA vaccines and therapeutics. With this collaboration, we want to develop mRNA vaccine product candidates with the potential to improve the lives of patients who suffer from certain autoimmune diseases and allergies.”

Medicine 98

Medicine Food Leads Patients 98